Skip to main content

Teladoc's CEO just explained why the Livongo merger is a winner

By Nasdaq  
   March 15, 2021

When Teladoc Health (NYSE: TDOC) announced it was acquiring Livongo Health in August of last year, both stocks sold off significantly. Whether it was the purchase price, shareholders in each not wanting to own the other, or skepticism over the combination, Wall Street didn't like the deal. Yet, after only one quarter of operating as a single entity, Teladoc is already pointing out the benefits of the combination.

Full story


Get the latest on healthcare leadership in your inbox.